SIREN : 889473443
LBDM BIO is a French company founded 5 years ago, specialized in the sector Commerce d'alimentation générale. Based in CROZON (29160), this company of category PME shows in 2024 a net income positive of 20 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C |
| Net income | 20 032 € | 3 289 € | 29 029 € | 6 961 € |
| EBITDA | N/C | N/C | N/C | N/C |
| Net margin | N/C | N/C | N/C | N/C |
In 2024, LBDM BIO generates positive net income of 20 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2024: 7 k€ -> 20 k€.
20 032 €
The debt ratio (= Financial debt / Equity x 100) stands at 262%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 23%. The balance between equity and debt is satisfactory.
261.569%
22.798%
52.0%
In 2024, the debt ratio of LBDM BIO (261.57) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of LBDM BIO (22.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
The liquidity ratio (= Current assets / Current liabilities) stands at 301.34. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
301.343
In 2024, the liquidity ratio of LBDM BIO (301.34) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Based on 551 transactions of similar company sales in 2024, the value of LBDM BIO is estimated at 116 700 € (range 52 644€ - 263 545€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 551 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare LBDM BIO with other companies in the same sector:
Voir toutes les statistiques du secteur Commerce d'alimentation générale
The revenue of LBDM BIO is not publicly disclosed (confidential accounts filed with INPI).
Yes, LBDM BIO generated a net profit of 20 k€ in 2024.
The headquarters of LBDM BIO is located in CROZON (29160), in the department Finistere.
The tax return of LBDM BIO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
LBDM BIO operates in the sector Commerce d'alimentation générale (NAF code 47.11B). See the 'Sector positioning' section above to compare the company with its competitors.